Big winners in 2015’s first half: Chinese and biotech ETFs

While Chinese stocks have slumped this month, they’re still leaders when it comes to year-to-date performance. Biotech funds also dominate a list of top-performing nonleveraged ETFs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.